Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COR-I: Naltrexone/Bupropion SR in Obesity
NCT00532779Phase 3Completed
- Sponsor
- Orexigen Therapeutics
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone + bupropion in obesity, Overweight, sponsored by Orexigen Therapeutics. Started Oct 2007; status: completed.
02
Drugs
naltrexone + bupropion
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00532779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532779.